Robustness of the healthcare utilization results from the Rotavirus Efficacy and Safety Trial (REST) evaluating the human-bovine (WC3) reassortant pentavalent rotavirus vaccine (RV5)

BACKGROUND: The Rotavirus Efficacy and Safety Trial was a placebo-controlled Phase III study that evaluated the safety and efficacy of a three-dose pentavalent rotavirus vaccine (RV5) including its effect on healthcare utilization for rotavirus gastroenteritis (RVGE). The per-protocol (PP) analyses,...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Itzler, Robbin, Koch, Gary, Matson, David O, Gothefors, Leif, Van Damme, Pierre, DiNubile, Mark J, Heaton, Penny M
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2010
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2905347/
https://ncbi.nlm.nih.gov/pubmed/20540778
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2431-10-42
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items